Retatrutide is a medication being studied for its potential to help people with severe obesity who also have heart disease. It is given once a week and is designed to help reduce body weight. The study aims to see how well it works and how safe it is for people with these health conditions. Retatrutide works by affecting certain hormones in the body that are involved in regulating appetite and metabolism, which may help people lose weight and improve their heart health.

Cardiovascular Disease – Cardiovascular disease refers to a group of disorders affecting the heart and blood vessels. It often begins with damage to the blood vessels, leading to the buildup of fatty deposits, known as plaques, which can narrow or block arteries. This process, called atherosclerosis, can progress over time and may result in reduced blood flow to the heart or brain. As the disease advances, it can lead to conditions such as coronary artery disease, heart attack, or stroke. The progression of cardiovascular disease can be influenced by factors like high blood pressure, high cholesterol, smoking, and diabetes. It is a chronic condition that can develop over many years.

Obesity – Obesity is a medical condition characterized by an excessive accumulation of body fat. It develops when the intake of calories exceeds the amount of energy expended over time, leading to weight gain. This condition can progress gradually, often starting with overweight and advancing to obesity as body mass index (BMI) increases. Obesity can lead to various health complications, including increased risk for type 2 diabetes, cardiovascular disease, and certain cancers. The progression of obesity is influenced by factors such as genetics, lifestyle, diet, and physical activity levels. It is a chronic condition that can have significant impacts on overall health and well-being.